![]() |
AGEN | Agenus Inc |
Biological Products (no Diagnostic Substances) |
Book value per $ invested | $ -0.23 |
Leverage | 222.58% |
Market Cap | $ 1.3B |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -233.0m |
Margin | -141.64% |
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.